---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-044808"
form_type: "8-K"
ticker: "ADMA"
cik: "0001368514"
company_name: "ADMA BIOLOGICS, INC."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:21:09.809128+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# ADMA Biologics engages KPMG as new auditor effective after Q3 2024 10-Q filing

## Summary
- KPMG appointed as independent registered public accounting firm on October 31, 2024, effective upon filing of Q3 2024 10-Q.
- No consultations or disagreements with KPMG during prior fiscal years 2022-2023 and interim period through October 31, 2024.
- KPMG will audit the consolidated financial statements for FY 2024, expected to be filed by March 3, 2025.

## SEC filing metadata
- accession: 0001140361-24-044808
- form_type: 8-K
- ticker: ADMA
- cik: 0001368514
- company_name: ADMA BIOLOGICS, INC.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 4.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1368514/000114036124044808/0001140361-24-044808-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1368514/000114036124044808/ef20037117_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-044808
- JSON: https://secwatch.observer/filing/0001140361-24-044808.json
- Plain text: https://secwatch.observer/filing/0001140361-24-044808.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.